NFKB1 and Alzheimer disease: Knockout of Trpa1 or blockade of TRPA1‐channel function by the selective antagonist HC‐030031 restores cognition and reduces Aβ plaque deposition and proinflammatory cytokine (IL‐1β, IL‐6, and IL‐4) release in AD mice through the Ca2+‐PP2B/NF‐κB signaling pathway [38].